D.E.A. Warns of ‘Alarming’ Increase in Fentanyl-Laced Fake Pills

The Drug Enforcement Administration said it had seized more than 9.5 million counterfeit prescription pills so far this year, more than in the previous two years combined.

The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen

Too often, seniors who use opioids become targets for exploitation and abuse.

U.S. Seeks to Block Bankruptcy Plan That Would Free Sacklers From Opioid Claims

The Justice Department has been appealing the deal, approved earlier this month.

Origins of an Epidemic: Purdue Pharma Knew Its Opioids Were Widely Abused (Published 2018)

A confidential Justice Department report found the company was aware early on that OxyContin was being crushed and snorted for its powerful narcotic, but continued to promote it as less addictive.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Richard Sackler Says Family and Purdue Bear No Responsibility for Opioid Crisis

In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.

Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from lawsuits related to Purdue Pharma.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Johnson & Johnson to Pay New York $230 Million to Settle Opioid Case

The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.

Judge Clears Purdue Pharma’s Restructuring Plan for Vote by Thousands of Claimants

The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.

Paul J. Hanly Jr., Top Litigator in Opioid Cases, Dies at 70

Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.